Your search returned 13 results.

Results
	1.	Pazopanib for the treatment of breast cancer. [Review] MedStar authors: Swain, Sandra M PMID: 22233389 Year: 2012 Citation: Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Review Form of publication: Journal Article All authors: Amiri-Kordestani L, Swain SM, Tan AR DOI: http://dx.doi.org/10.1517/13543784.2012.652304 Add to cart (remove)
	2.	Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer. [Review] MedStar authors: Swain, Sandra M PMID: 23530718 Year: 2013 Citation: Expert Opinion on Biological Therapy. 13(5):779-90, 2013 May. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Review Form of publication: Journal Article All authors: O'Sullivan CC, Swain SM DOI: http://dx.doi.org/10.1517/14712598.2013.783007 Add to cart (remove)
	3.	The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 24885258 Year: 2014 Citation: BMC Cancer. 14:307, 2014. Institution: Washington Cancer Institute Medline publication type: Clinical Trial Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B DOI: http://dx.doi.org/10.1186/1471-2407-14-307 Add to cart (remove)
	4.	Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors: Swain, Sandra M PMID: 25559813 Year: 2015 Citation: Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1200/JCO.2014.56.2439 Add to cart (remove)
	5.	Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors: Asch, Federico M Barac, Ana Herbolsheimer, Pia M Lynce, Filipa Mete, Mihriye Nunes, Raquel Shara, Nawar M Swain, Sandra M Wray, Lynette PMID: 26749359 Year: 2016 Citation: Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan. Institution: MedStar Health Research Institute MedStar Health Research Institute MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Washington Cancer Institute Washington Cancer Institute Washington Cancer Institute A Washington Cancer Instituteia Department: MedStar Heart Institute MedStar Heart Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L Add to cart (remove)
	6.	Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors: Swain, Sandra M PMID: 27812689 Year: 2017 Citation: JAMA Oncology. 3(3):335-341, 2017 Mar 01 Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N DOI: https://dx.doi.org/10.1001/jamaoncol.2016.4884 Add to cart (remove)
	7.	The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. MedStar authors: Howard, Barbara V PMID: 29063981 Year: 2018 Citation: Breast Cancer Research & Treatment. 167(3):741-749, 2018 02. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Beebe-Dimmer JL, Bock CH, Cote ML, Desai P, Dyson G, Hou L, Howard BV, Jay AM, Prentice R, Purrington K, Simon MS DOI: https://dx.doi.org/10.1007/s10549-017-4521-0 Add to cart (remove)
	8.	SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors: Asch, Federico M Barac, Ana Lynce, Filipa Swain, Sandra M PMID: 28314836 Year: 2017 Citation: Oncologist. 22(5):518-525, 2017 May Institution: MedStar Heart & Vascular Institute Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT DOI: https://dx.doi.org/10.1634/theoncologist.2016-0412 Add to cart (remove)
	9.	NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. MedStar authors: Swain, Sandra M PMID: 32371537 Year: 2020 Citation: Clinical Cancer Research. 26(16):4233-4241, 2020 08 15. Institution: MedStar Health Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Bandos H, Brauer HA, Geyer CE Jr, Goerlitz DS, Harris BT, Lucas PC, Mamounas EP, Rastogi P, Ren Y, Robidoux A, Swain SM, Tang G, Wolmark N DOI: https://dx.doi.org/10.1158/1078-0432.CCR-20-0152 Add to cart (remove)
	10.	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors: Blackburn, Matthew J Chitalia, Ami Dilawari, Asma Gallagher, Christopher Lynce, Filipa Mohebtash, Mahsa Tiwari, Shruti R PMID: 34157782 Year: 2021 Citation: Cancer. 127(19):3622-3630, 2021 10 01. Institution: MedStar Franklin Square Cancer Center at Loch Raven Campus MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology & Oncology Fellowship Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R DOI: https://dx.doi.org/10.1002/cncr.33620 Add to cart (remove)
	11.	Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. MedStar authors: McCarron, Edward C PMID: 38301187 Year: 2024 Citation: Journal of Clinical Oncology. 42(11):1288-1300, 2024 Apr 10. Institution: MedStar Franklin Square Medical Center Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ DOI: Click here to access online Add to cart (remove)
	12.	What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?. MedStar authors: Whitaker, Kristen PMID: 38776577 Year: 2024 Citation: Journal of Surgical Research. 299:217-223, 2024 Jul. Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Forester E, Belsare A, Kim DW, Whitaker K, Obeid E, Goldstein LJ, Bleicher RJ, Daly MB, Williams AD DOI: https://dx.doi.org/10.1016/j.jss.2024.04.032 Add to cart (remove)
	13.	Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC). MedStar authors: Swain, Sandra M PMID: 39706338 Year: 2025 Citation: Annals of Oncology. 36(4):403-413, 2025 Apr. Department: Associate Dean for Research Development MedStar Health Medline publication type: Journal Article Form of publication: Journal Article All authors: Fernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA DOI: Click here to access online Add to cart (remove)